L2 Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

L2 Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $1.06 Million - $1.29 Million	-1,531 Reduced 98.58%	22 $18,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $275,111 - $326,327	-393 Reduced 20.2%	1,553 $1.12 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $379,713 - $461,449	558 Added 40.2%	1,946 $1.6 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $231,883 - $292,625	404 Added 41.06%	1,388 $956,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $539,576 - $727,018	984 New	984 $582,000

1,496

82.9M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on L2 Asset Management, LLC with notifications on news.